NuVasive logo
NuVasive NUVA

Quarterly report 2023-Q2
added 08-02-2023

report update icon

NuVasive Income Statement 2011-2026 | NUVA

Annual Income Statement NuVasive

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.29 B 2.68 B 2.76 B 4.09 B 2.5 B 2.54 B 3.49 B 2.25 B 2.16 B 1.69 B 751 M 630 M

Shares

52 M 51.6 M 51.4 M 52 M 51.4 M 50.9 M 50.1 M 48.7 M 46.7 M 44.5 M 43.3 M 40.4 M

Historical Prices

44.1 52 53.7 77.1 50.1 48.9 70.8 46.1 46.3 37.4 17.2 15.5

Net Income

40.4 M -64.1 M -37.2 M 65.2 M 12.5 M 83 M 37.1 M 66.3 M -16.7 M 7.9 M 3.14 M -69.8 M

Revenue

1.2 B 1.14 B 1.05 B 1.17 B 1.1 B 1.03 B 962 M 811 M 762 M 685 M 620 M 541 M

Cost of Revenue

337 M 322 M 322 M 312 M 311 M 268 M 240 M - - - - -

Gross Profit

865 M 817 M 729 M 856 M 791 M 761 M 722 M 617 M 580 M 505 M 467 M 428 M

Interest Expense

-21.4 M -25.5 M -16.9 M -5.92 M -8.17 M -1.54 M -305 K 425 K -2.41 M 3.1 M 1.05 M 2.08 M

EBITDA

147 M 150 M 141 M 172 M 153 M 170 M 140 M 116 M 72.4 M 52.4 M 59.1 M 40.9 M

Operating Expenses

777 M 829 M 691 M 735 M 688 M 638 M 624 M 513 M 521 M 472 M 420 M 394 M

General and Administrative Expenses

634 M 610 M 547 M 611 M 576 M 540 M 534 M 465 M 470 M 420 M 372 M 347 M

All numbers in USD currency

Quarterly Income Statement NuVasive

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

52.4 M 52.2 M 52.1 M 52.1 M 52 M 51.8 M 51.8 M 51.7 M 51.6 M 51.4 M 51.4 M 51.3 M 51.2 M 51.8 M 52.1 M 52.1 M 52 M 51.7 M 56.6 M 51.4 M 51.4 M 51.2 M 56.2 M 50.7 M 51.1 M 50.6 M 55.2 M 50.3 M 50 M 49.6 M 52.6 M 49 M 48.5 M 48 M 47.7 M 47 M 46.8 M 45.8 K 44.9 M 44.6 M 44.4 M 44 M 43.7 M 43.5 M 43.3 M 42.8 M 42.5 M 39.9 M 39.8 M 39.6 M

Net Income

7.36 M -1.01 M - -1.98 M -893 K 19.2 M - -21.6 M 1.8 M -7.51 M - 5.87 M -50 M 5.3 M 29.9 M 11 M 15 M 9.39 M 12.2 M 15.9 M 11.5 M -27.1 M 23.5 M 33.5 M 12.2 M 12.4 M 6.38 M 3.93 M 30.2 M -3.37 M 11.5 M 13 M 10.3 M 31.6 M 7.47 M -1.83 M -4.09 M -18.3 M 6.01 M 7.51 M -6.47 M 851 K -2.75 M 2.35 M 2.86 M 673 K -10 M -67.6 M 5.38 M 2.36 M

Revenue

318 M 308 M - 295 M 310 M 291 M - 271 M 295 M 271 M - 295 M 204 M 260 M 310 M 291 M 292 M 275 M 288 M 271 M 282 M 261 M 271 M 247 M 259 M 249 M - - - - - - - - - - - - 191 M 169 M 166 M 160 M 166 M 148 M 154 M 152 M - - - -

Cost of Revenue

89.5 M 86.4 M - 80.9 M 85.8 M 79.1 M - 88.7 M 78.3 M 71.8 M - 84.6 M 80.5 M 71.9 M - 77 M 77.6 M 74.5 M - 74.2 M 77.1 M 73.8 M - 65.5 M 66.2 M 61.4 M - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

228 M 221 M - 214 M 225 M 212 M - 182 M 217 M 199 M - 211 M 123 M 188 M 227 M 214 M 215 M 200 M 202 M 197 M 205 M 187 M 196 M 182 M 193 M 188 M 204 M 180 M 176 M 161 M 164 M 151 M 154 M 147 M 158 M 142 M 146 M 134 M 141 M 126 M 117 M 120 M 124 M 111 M 118 M 115 M 113 M 107 M 107 M 101 M

Interest Expense

-826 K -4.44 M - -21.1 M -29.7 M 16.2 M - -13.1 M 1.27 M -12.5 M - 251 K -11.7 M -7.41 M - -5.7 M 9 K -366 K - 4.24 M -2.38 M -9.7 M - -139 K -501 K 258 K - 94 K -246 K 50 K - 387 K -281 K 424 K - -2.49 M -205 K 375 K - 3.14 M -440 K 240 K - 260 K -551 K 437 K - 1.73 M 80 K 497 K

EBITDA

8 M 33.5 M - 110 M 13.4 M 36.8 M - 112 M 15.9 M 36.4 M - 106 M 70.1 M 35 M - 101 M 67.6 M 34.1 M - 96.4 M 64.2 M 32.1 M - 88.9 M 58.7 M 29.5 M - 73.8 M 46.3 M 21.2 M - 49 M 32.6 M 16.1 M - 46.5 M 31 M 15.4 M - 46.3 M 30.3 M 14.6 M - 38.2 M 25.3 M 12.1 M - 24.8 M 15.9 M 7.78 M

Operating Expenses

210 M 214 M - 193 M 192 M 200 M - 189 M 206 M 187 M - 184 M 160 M 160 M - 183 M 184 M 180 M - 179 M 176 M 205 M - 151 M 164 M 165 M - 159 M 116 M 149 M - 123 M 129 M 91.2 M - 126 M 141 M 162 M - 114 M 117 M 114 M - 98.1 M 105 M 108 M - 198 M 96 M 96.3 M

General and Administrative Expenses

164 M 176 M - 154 M 161 M 160 M - 146 M 157 M 146 M - 146 M 126 M 130 M - 153 M 153 M 145 M - 141 M 146 M 147 M - 126 M 139 M 140 M - 132 M 134 M 125 M - 111 M 115 M 116 M - 114 M 117 M 118 M - 102 M 104 M 99.9 M - 87.4 M 92.6 M 94.7 M - 85.5 M 84.3 M 84.2 M

All numbers in USD currency

The income statement is one of the three key financial reports of a company NuVasive (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
- - $ 1.05 B usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.6 4.2 % $ 135 M franceFrance
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.22 2.78 % $ 1.35 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.47 3.33 % $ 325 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 17.12 0.47 % $ 402 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.57 -5.8 % $ 35.5 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 66.26 15.05 % $ 3.61 B britainBritain
Delcath Systems Delcath Systems
DCTH
$ 11.26 -2.34 % $ 403 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.04 -0.95 % $ 17.6 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Electromed Electromed
ELMD
- 0.5 % $ 219 M usaUSA
Myomo Myomo
MYO
$ 0.85 -2.78 % $ 35.6 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 4.55 -5.6 % $ 963 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 12.19 -2.01 % $ 483 M curacaoCuracao
Insulet Corporation Insulet Corporation
PODD
- - $ 10.6 B usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
Globus Medical Globus Medical
GMED
$ 89.22 -0.9 % $ 12.1 B usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.4 -0.83 % $ 6.66 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 37.32 1.86 % $ 1.16 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 45.7 -5.42 % $ 1.34 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 86.29 0.51 % $ 3 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 292.33 -0.99 % $ 112 B usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 83.2 0.35 % $ 48.7 B usaUSA
TransMedics Group TransMedics Group
TMDX
- - $ 2.48 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 25.3 5.2 % $ 579 M usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
- - $ 1.23 B usaUSA
LENSAR LENSAR
LNSR
$ 5.39 -1.73 % $ 64.5 M usaUSA